QA: Rhythm Pharmaceuticals INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001649904_2024_Rhythm_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001649904', 'EntityCommonStockSharesOutstanding': 59096454, 'Assets': 332745000, 'AssetsCurrent': 308268000, 'ComprehensiveNetIncome': -184452000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 7028000, 'Liabilities': 162986000, 'LiabilitiesAndStockholdersEquity': 332745000, 'LiabilitiesCurrent': 55203000, 'LiabilitiesNoncurrent': 490000, 'NetIncome': -184678000, 'PropertyPlantAndEquipmentNet': 1341000, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 16108000, 'remainder_ComprehensiveNetIncome': 226000, 'remainder_Expenses': 0, 'remainder_Liabilities': 107293000, 'remainder_LiabilitiesAndStockholdersEquity': 169759000, 'remainder_NetIncome': 0, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 2, '00205 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (calc 2)': 3}}

Edgar->Model Mapping